LATEST

There are no tropical cyclones at this time.✦3 killed, 7 Injured as Speeding Jeep Crashes into Tree in Nanded✦Keralam Excise Minister says Vigilance probe to be recommended against suspended officials; new liquor policy by September-end✦Indian among 12 killed in latest Russian attacks on Ukraine: Zelenskyy✦Accused in Congress Leader Mahesh Murder Case Dies in Warangal✦

GSK's MRNA Flu Vaccine Candidate Advances To Phase III Trial

By Dhallo News · September 1, 2026 at 1:48 PM IST

(RTTNews) - GSK plc (GSK) will advance its investigational mRNA seasonal flu vaccine candidate into Phase III testing after Phase II results showed stronger immune responses compared to standard and high dose flu vaccines in both younger and older adults. The company presented th

Original reporting: NasdaqRead original report →

Have feedback on this article?Report error or suggestion

Read More from Markets

Unacademy’s $3.44 billion valuation to $200 million acquisition by upGrad: Gaurav Munjal reflects on journey

upGrad has completed its acquisition of Unacademy for just over $200 million, fa...

Read Article »

This High-Yield Pipeline Stock Could Turn $450 a Month Into a Six-Figure Portfolio Paying Real Annual Income

Key PointsOil and gas pipeline stocks generate revenue based on the volume usage...

Read Article »

IPO-bound Parle Products appoints former PepsiCo executive George Kovoor as CEO

Kovoor spent over 30 years at PepsiCo across geographies, including China and th...

Read Article »

Return to Front Page

5 minutes. The news that matters.

Get the most important stories of the day, without having to browse hundreds of articles.